文献速递冠心病

年轻急性冠脉综合征患者的大麻使用:对初始表现及长期预后的影响

Cannabis use among young adults with acute coronary syndrome: impact on initial presentation and long-term prognosis.
PubMed 文献 · Heart · 2026-09-24

该回顾性单中心队列纳入2010年1月1日至2025年3月1日期间因急性冠脉综合征(ACS)入院且年龄小于45岁、入院时均报告当前吸烟的患者,依据入院尿检分为大麻使用者和非使用者。中位随访2.93年,加权分析显示大麻使用与主要不良心血管事件(MACE)风险升高相关(HR 2.52,95%CI 1.05-6.02;p=0.04)。

要点

  • 年轻ACS患者中大麻使用与6年内MACE风险升高约2.5倍相关。
  • 大麻使用者峰值肌钙蛋白和白细胞计数更高。
  • 心血管照护路径中应纳入大麻使用评估。

核心结论

  • 年轻ACS患者中大麻使用与6年内MACE风险升高相关(HR 2.52,95%CI 1.05-6.02;p=0.04)。

研究设计与样本

  • 回顾性单中心队列研究,纳入2010年1月1日至2025年3月1日因ACS入院、年龄小于45岁且入院时报告当前吸烟的患者188例。
  • 依据入院尿检将患者分为大麻使用者(77例,41.0%)和非使用者(111例,59.0%)。
  • 采用倾向加权分析调整社会经济和心血管危险因素,并绘制加权生存曲线,使用截断于6年的Cox模型估计MACE的风险比。

主要发现

  • 中位随访2.93(0.45-5.53)年。
  • 加权Kaplan-Meier曲线差异显著(Fleming-Harrington p=0.002),大麻使用者MACE累积发生率更高。
  • 在逆概率处理加权Cox模型中,大麻使用与MACE风险升高相关(HR 2.52,95%CI 1.05-6.02;p=0.04)。
  • 大麻使用者峰值肌钙蛋白水平更高、白细胞计数更高、术后抗凝使用更多(均p<0.05)。

临床怎么用

  • 在年轻ACS患者的心血管照护路径中应考虑评估大麻使用情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cannabis consumption has increased among young adults, but its long-term cardiovascular impact remains unclear. This study assessed the association between cannabis use at admission for acute coronary syndrome (ACS) and long-term prognosis. METHODS: A retrospective, single-centre cohort included patients under the age of 45 years admitted for ACS between 1 January 2010 and 1 March 2025, all of whom reported current tobacco use at admission. Based on urinary testing at admission, patients were classified as cannabis users or non-users. The primary endpoint was major adverse cardiovascular events (MACE), a composite of death, stroke, recurrent myocardial infarction, arrhythmia or heart failure-related events. A propensity-weighted analysis adjusted for socioeconomic and cardiovascular risk factors was conducted. Weighted survival curves were plotted, and a Cox model truncated at 6 years was used to estimate the HR for MACE associated with cannabis use. RESULTS: Among 188 included patients, 77 (41.0%) were cannabis users and 111 (59.0%) non-users. The median follow-up was 2.93 (0.45-5.53) years. Weighted Kaplan-Meier curves differed significantly (Fleming-Harrington p=0.002), with a higher cumulative incidence of MACE among cannabis users. In the inverse probability of treatment weighting Cox model, cannabis use was associated with a higher hazard of MACE (HR 2.52, 95% CI 1.05 to 6.02; p=0.04). Cannabis users also had higher peak troponin levels, higher leucocyte counts and a greater use of postprocedural anticoagulation (all p<0.05). CONCLUSIONS: Cannabis use in young adults with ACS was associated with a 2.5-fold higher hazard of MACE over 6 years, highlighting the need to take cannabis use into account in cardiovascular care pathways.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Martin, Beyls, Zeitouni, et al. Cannabis use among young adults with acute coronary syndrome: impact on initial presentation and long-term prognosis. Heart. 2026. PMID: 41176318. doi:10.1136/heartjnl-2025-326777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。